• Company overview
  • About Siena Biotech
  •    Mission
  •    Board of directors
  •    Management
  •    Scientific Advisory Board
  •    Ethics commitee
  • Medicines Research Centre
  • Contact us
• Investors
  • MPS Foundation
  • Sansedoni Siena
• Portfolio
  • Pipeline
  • Therapeutic Areas
  •    Neurodegeneration
  •    Oncology
  • Platforms
• Partnering
  • Partnering Strategy
  • Our Partners
  • Business contacts
• News
  • News
  • Selected Publications

Who we are

Siena Biotech S.p.A. is an innovative, clinical-stage drug discovery company whose R&D efforts are focused on discovering new drugs for therapeutic intervention against neurodegenerative diseases and oncology.

Development Pipeline   View Complete Pipeline >>

News 29/07/2010 Aptuit and Siena Biotech announce Strategic Relationship in Italy  >> 13/07/2010 Siena Biotech renewed the Scientific Advisory Board. Members of Siena Biotech Ethics Committee were confirmed.  >>